Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Terumo Ties Up with Spenser Technologies of the US in Diagnosis of Cerebral, Cardiac Diseases
August 23, 2004
- Nippon Chemiphar Aims at Reaching 16-17% of Ordinary Profit Ratio to Sales by FY 2008: Mr Yamaguchi
August 23, 2004
- MEDICAL DEVICE NEWS IN BRIEF
August 23, 2004
- 1st Qtr Business Results
August 23, 2004
- BULLETIN
August 23, 2004
- 1st Qtr Business Results
August 23, 2004
- Monkasho Project on Molecular Imaging Techniques to Start from FY2005
August 23, 2004
- Semi-annual Business Results
August 23, 2004
- MONITOR
August 23, 2004
- NEW PRODUCTS
August 23, 2004
- Meet the Leaders (35)
August 23, 2004
- Precautions Revised for 4 Drugs Including Clarithromycin
August 23, 2004
- Daiichi to Return to Track of Growth via Structural Reform
August 23, 2004
- REGULATORY NEWS IN BRIEF
August 23, 2004
- Aiming at Sales of \120 Bil. in 2010: Mr Crenshaw of Eli Lilly Japan
August 23, 2004
- NHO Plans to Improve Domestic Clinical Trials
August 23, 2004
- Eisai to Triple Production of Aricept, Pariet at Kashima Plant
August 23, 2004
- BULLETIN
August 23, 2004
- Mr Komine of MPC Stresses Medicoeconomic Benefits of Zione
August 23, 2004
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
August 23, 2004
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…